447 related articles for article (PubMed ID: 30468885)
1. Obeticholic acid alleviate lipopolysaccharide-induced acute lung injury via its anti-inflammatory effects in mice.
Fei J; Fu L; Hu B; Chen YH; Zhao H; Xu DX; Li JB
Int Immunopharmacol; 2019 Jan; 66():177-184. PubMed ID: 30468885
[TBL] [Abstract][Full Text] [Related]
2. Obeticholic Acid Protects against Lipopolysaccharide-Induced Fetal Death and Intrauterine Growth Restriction through Its Anti-Inflammatory Activity.
Chen YH; Hu XG; Zhou Y; Yu Z; Fu L; Zhang GB; Bo QL; Wang H; Zhang C; Xu DX
J Immunol; 2016 Dec; 197(12):4762-4770. PubMed ID: 27821667
[TBL] [Abstract][Full Text] [Related]
3. Obeticholic acid differentially regulates hepatic injury and inflammation at different stages of D-galactosamine/lipopolysaccharide-evoked acute liver failure.
Ding W; Fan YY; Zhang C; Fu L; Chen X; Xu DX
Eur J Pharmacol; 2019 May; 850():150-157. PubMed ID: 30772394
[TBL] [Abstract][Full Text] [Related]
4. Farnesoid X receptor agonist obeticholic acid inhibits renal inflammation and oxidative stress during lipopolysaccharide-induced acute kidney injury.
Zhu JB; Xu S; Li J; Song J; Luo B; Song YP; Zhang ZH; Chen YH; Xie DD; Yu DX; Xu DX
Eur J Pharmacol; 2018 Nov; 838():60-68. PubMed ID: 30196109
[TBL] [Abstract][Full Text] [Related]
5. Obeticholic acid protects against carbon tetrachloride-induced acute liver injury and inflammation.
Zhang DG; Zhang C; Wang JX; Wang BW; Wang H; Zhang ZH; Chen YH; Lu Y; Tao L; Wang JQ; Chen X; Xu DX
Toxicol Appl Pharmacol; 2017 Jan; 314():39-47. PubMed ID: 27865854
[TBL] [Abstract][Full Text] [Related]
6. Obeticholic acid protects mice against lipopolysaccharide-induced liver injury and inflammation.
Xiong X; Ren Y; Cui Y; Li R; Wang C; Zhang Y
Biomed Pharmacother; 2017 Dec; 96():1292-1298. PubMed ID: 29174575
[TBL] [Abstract][Full Text] [Related]
7. Glycitin alleviates lipopolysaccharide-induced acute lung injury via inhibiting NF-κB and MAPKs pathway activation in mice.
Chen Y; Guo S; Jiang K; Wang Y; Yang M; Guo M
Int Immunopharmacol; 2019 Oct; 75():105749. PubMed ID: 31306981
[TBL] [Abstract][Full Text] [Related]
8. Sclareol ameliorate lipopolysaccharide-induced acute lung injury through inhibition of MAPK and induction of HO-1 signaling.
Hsieh YH; Deng JS; Pan HP; Liao JC; Huang SS; Huang GJ
Int Immunopharmacol; 2017 Mar; 44():16-25. PubMed ID: 28068646
[TBL] [Abstract][Full Text] [Related]
9. Mogroside IIIE Attenuates LPS-Induced Acute Lung Injury in Mice Partly Through Regulation of the TLR4/MAPK/NF-κB Axis via AMPK Activation.
Tao L; Cao F; Xu G; Xie H; Zhang M; Zhang C
Phytother Res; 2017 Jul; 31(7):1097-1106. PubMed ID: 28512854
[TBL] [Abstract][Full Text] [Related]
10. The novel N-methyl-d-aspartate receptor antagonist MN-08 ameliorates lipopolysaccharide-induced acute lung injury in mice.
Jiang J; Jian Q; Jing M; Zhang Z; Zhang G; Shan L; Yu P; Wang Y; Xu L
Int Immunopharmacol; 2019 Jan; 66():109-118. PubMed ID: 30447529
[TBL] [Abstract][Full Text] [Related]
11. Isorhamnetin protects mice from lipopolysaccharide-induced acute lung injury via the inhibition of inflammatory responses.
Chi G; Zhong W; Liu Y; Lu G; Lü H; Wang D; Sun F
Inflamm Res; 2016 Jan; 65(1):33-41. PubMed ID: 26525359
[TBL] [Abstract][Full Text] [Related]
12. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice.
San Z; Fu Y; Li W; Zhou E; Li Y; Song X; Wang T; Tian Y; Wei Z; Yao M; Cao Y; Zhang N
Int Immunopharmacol; 2014 Apr; 19(2):342-50. PubMed ID: 24548765
[TBL] [Abstract][Full Text] [Related]
14. Total flavonoids of Mosla scabra leaves attenuates lipopolysaccharide-induced acute lung injury via down-regulation of inflammatory signaling in mice.
Chen J; Wang JB; Yu CH; Chen LQ; Xu P; Yu WY
J Ethnopharmacol; 2013 Jul; 148(3):835-41. PubMed ID: 23747643
[TBL] [Abstract][Full Text] [Related]
15. Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice.
Zhong WT; Wu YC; Xie XX; Zhou X; Wei MM; Soromou LW; Ci XX; Wang DC
Fitoterapia; 2013 Oct; 90():132-9. PubMed ID: 23751215
[TBL] [Abstract][Full Text] [Related]
16. Tenuigenin ameliorates acute lung injury by inhibiting NF-κB and MAPK signalling pathways.
Lv H; Zhu C; Liao Y; Gao Y; Lu G; Zhong W; Zheng Y; Chen W; Ci X
Respir Physiol Neurobiol; 2015 Sep; 216():43-51. PubMed ID: 25930113
[TBL] [Abstract][Full Text] [Related]
17. Isotetrandrine protects against lipopolysaccharide-induced acute lung injury by suppression of mitogen-activated protein kinase and nuclear factor-kappa B.
Liang XM; Guo GF; Huang XH; Duan WL; Zeng ZL
J Surg Res; 2014 Apr; 187(2):596-604. PubMed ID: 24331940
[TBL] [Abstract][Full Text] [Related]
18. Acanthoic acid ameliorates lipopolysaccharide-induced acute lung injury.
Qiushi W; Guanghua L; Guangquan X
Eur J Pharmacol; 2015 Mar; 750():32-8. PubMed ID: 25620130
[TBL] [Abstract][Full Text] [Related]
19. Tetrahydroberberrubine attenuates lipopolysaccharide-induced acute lung injury by down-regulating MAPK, AKT, and NF-κB signaling pathways.
Yu X; Yu S; Chen L; Liu H; Zhang J; Ge H; Zhang Y; Yu B; Kou J
Biomed Pharmacother; 2016 Aug; 82():489-97. PubMed ID: 27470389
[TBL] [Abstract][Full Text] [Related]
20. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corcetto F; Corno C; Maneschi E; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L
J Steroid Biochem Mol Biol; 2017 Apr; 168():26-37. PubMed ID: 28115235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]